It’s highly unlikely that the sun will prevent you from catching COVID-19. And it could hurt you, too. Here’s what you need to know.
It’s highly unlikely that the sun will prevent you from catching COVID-19. And it could hurt you, too. Here’s what you need to know.
How Anna Nichols used her Skin Cancer Foundation research grant to kick-start an exciting and promising experimental treatment for skin cancer.
Given recent news reports, you may be wondering if sunscreens are safe for you and your family, as well as the planet. Elizabeth Buzney, MD, an expert and member of our Photobiology Committee, helps sort it all out.
Despite how often CSCC occurs, many Americans don’t seem to know much about it, especially in comparison to melanoma.
April Franzino, beauty director for magazine brands Good Housekeeping, Woman’s Day and Prevention, shared her insights on how far we’ve come and how sun-protective behaviors continue to evolve.
You need sun protection as much as you need vitamin D. You can have both, without skin damage or nutritional deficiency. A dermatologist tells you how.
According to a new study, melanoma patients with a history of smoking are more likely to die from the disease than patients who do not smoke. The study, funded by Cancer Research UK and published in the journal Cancer Research, found that melanoma patients with a history of smoking cigarettes are 40 percent less likely to survive the disease than those who have never smoked.
Why do some people seem to be resistant to skin cancer, while many of us (who regularly visit SkinCancer.org) seem prone to it? Turns out there’s a gene that’s at least partially responsible, according to a 2016 study.
We saw the FDA approve a groundbreaking drug, companies debut new technology to help increase our awareness of dangerous ultraviolet (UV) rays and lawmakers pass indoor tanning legislation.
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
English
Chinese (Simplified)
French
German
Italian
Portuguese
Spanish